Biotecnología
Biotecnología
Orna Therapeutics Acquires ReNAgade Therapeutics
27/05/2024 -
Will combine its circular RNA expression technology with ReNAgade's portfolio of LNP-based RNA delivery systems and editing programs.
Johnson & Johnson Agrees to Acquire Proteologix
27/05/2024 -
Will integrate Proteologix’s bispecific antibodies into its pipeline.
NEOsphere, Kymera Therapeutics Collaborate on Novel Molecular Glue Target Discovery
16/05/2024 -
Aim to create opportunities to target previously undruggable disease-causing proteins.
TriLink Invests in New RNA Innovation Center at Johns Hopkins
14/05/2024 -
Will accelerate transformational research in RNA therapeutics and discovery.
Ingenza Secures Innovation Funding to Expand codABLE Gene Design Algorithm
06/05/2024 -
Will adapt its machine learning platform to precisely control recombinant protein expression in Pichia pastoris.
MiLaboratories, Miltenyi Biotec Enter Genomics Alliance
02/05/2024 -
Combines MiLaboratories' RNA kit technology for immune sequencing with Miltenyi Biotec's production and commercialization capabilities.
Fujifilm & Predictive Oncology Tackle Protein Interference
02/05/2024 -
Enter a collaboration and co-marketing agreement to reduce protein interference in bacterial endotoxin testing of biopharmaceutical products.
Abzena Introduces Enhanced Bioassay Platform
02/05/2024 -
EpiScreen 2.0 predicts and evaluates potential risks of preclinical immunogenicity in protein, antibody and gene therapy therapeutics.
Ipsen and Skyhawk Therapeutics Collaborate on RNA Targeting Research
25/04/2024 -
Aim to discover and develop small molecules for the treatment of rare neurological diseases.
Charles River & Axovia Partner to Support Development of Gene Therapies for Ciliopathies
10/04/2024 -
Axovia will leverage Charles River’s plasmid platform and expertise in plasmid DNA production to accelerate time to clinic.
Ship of Theseus Taps Charles River as Manufacturing Partner
08/04/2024 -
Charles River to support the development of novel HOX-based therapies through plasmid DNA manufacturing.
Lonza Expands Spray-Drying Services for Protein-Based Inhaled Therapies
03/04/2024 -
New offering provides clinical and commercial manufacturing services at a kilogram scale from Lonza’s Bend (US) site.
Exothera Launches Nucleic Acids Service Offering Powered by Ntensify
27/03/2024 -
Continuous batch production of RNA service significantly cuts clinical development time while enhancing quality and yield.
Samsung Life Science Fund Invests in BrickBio
24/03/2024 -
Samsung affiliates will work with BrickBio to evaluate, manufacture, and develop therapies using BrickBio's protein engineering technology.
BostonGene Named Akoya Biosciences' Qualified CRO
24/03/2024 -
Will offer end-to-end spatial biology solutions to life sciences researchers for advanced spatial proteomics analysis.
ProteoNic Biosciences Partners with Ginkgo Bioworks to Support Clients
15/03/2024 -
Grants Ginkgo Bioworks’ customers access to ProteoNic's vector technology.
Key Proteo to Build New CLIA-Certified Lab
11/03/2024 -
Aims to expand its scope of operations to serve unaddressed newborn screening needs.
New Ways to Predict How Well Vaccines Protect Against Tuberculosis, Tularemia and Other Bacteria That Live Inside Cells
07/03/2024 -
A description of Karen Elkins's research program and related publications.
Evaluating New Approaches to Developing AIDS Vaccines by Creating Virus-like Particles that Display HIV Antigens or by Using Live, Attenuated (Weakened), non-HIV Viruses to Express HIV Proteins
07/03/2024 -
A description of Ira Berkower's research program and related publications.
Polyplus Receives GMP Certification for Recombinant Protein & DNA Production
07/03/2024 -
Also adds an additional GMP clean room for the production of GMP cell banks.
Ginkgo Bioworks Acquires Patch Biosciences
29/02/2024 -
Strengthens its Gene Therapy Services, Cell Therapy Services, and RNA Therapeutics Services.
